By targeting three different receptors, retatrutide may reduce appetite, lead to significant fat loss, and all while brilliantly maintaining metabolism
These challenges are not unique to peptides and increasingly characterize modern therapeutics across oncology, neurology, and immunology
It is incredibly important as a healthcare system that we start treating obesity as a long-term condition and wrap care around people living with obesity, which may include diet, lifestyle, psychological support and, for some people, medication to help them manage and lower their weight. 1.Wharton S, Freitas P, Hjelmesth J, et al
We need to treat it like one, just like we treat hypertension or high cholesterol. Two GLP-1 agonists and one dual GIP/GLP-1 agonist are currently FDA-approved to treat obesity
By systematically examining this wide array of disorders, the study sheds light on the potential therapeutic roles of GLP-1RAs beyond their established metabolic applications
If you're waiting to start semaglutide due to cost: Generic oral semaglutide (expected 2027) will likely be priced at $100-$200 per month based on typical generic pricing for specialty drugs
